Zentalis Pharmaceuticals Inc
ZNTL
NASDAQ
Biotechnology
$3.56
USD
-0.59 (-14.22%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $316.55M
Volume 4.6M
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
FHTX | Foghorn Therapeutics Inc | $385.41M | - | +52.0% | - | |
PALI | Palisade Bio Inc | $368.58M | - | - | - | |
ABEO | Abeona Therapeutics Inc | $363.91M | 5.50 | - | - | |
DMAC | DiaMedica Therapeutics Inc | $360.76M | - | - | - | |
STRO | Sutro Biopharma Inc | $360.08M | - | +49.9% | - | |
GALT | Galectin Therapeutics Inc | $356.00M | - | - | - | |
IPSC | Century Therapeutics Inc | $348.08M | - | - | - | |
SABS | SAB Biotherapeutics Inc | $345.75M | 26.05 | - | - | |
LYEL | Lyell Immunopharma Inc | $336.70M | - | -52.3% | - | |
ZNTL | Zentalis Pharmaceuticals Inc | $316.55M | - | - | - |
Top Peer by Growth
Foghorn Therapeutics Inc
+52.0% YoY Revenue
Lowest P/E Ratio
Abeona Therapeutics Inc
5.50x P/E
Best 1-Year Return
Century Therapeutics Inc
+278.4% Return